STAAR Surgical Company (STAA)
STAA Stock Price Chart
Explore STAAR Surgical Company interactive price chart. Choose custom timeframes to analyze STAA price movements and trends.
STAA Company Profile
Discover essential business fundamentals and corporate details for STAAR Surgical Company (STAA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
IPO Date
24 Feb 1992
Employees
1.16K
Website
https://www.staar.comCEO
Stephen C. Farrell CFA
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
STAA Financial Timeline
Browse a chronological timeline of STAAR Surgical Company corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 9 Feb 2026
Upcoming earnings on 29 Oct 2025
EPS estimate is $0.18, while revenue estimate is $92.15M.
Earnings released on 6 Aug 2025
EPS came in at -$0.07 surpassing the estimated -$0.56 by +87.50%, while revenue for the quarter reached $44.32M , missing expectations by -50.29%.
Earnings released on 7 May 2025
EPS came in at -$0.52 surpassing the estimated -$0.59 by +11.86%, while revenue for the quarter reached $42.59M , beating expectations by +5.68%.
Earnings released on 11 Feb 2025
EPS came in at -$0.50 falling short of the estimated $0.02 by -2.60K%, while revenue for the quarter reached $48.95M , missing expectations by -36.82%.
Earnings released on 30 Oct 2024
EPS came in at $0.37 surpassing the estimated $0.19 by +94.74%, while revenue for the quarter reached $88.59M , beating expectations by +13.82%.
Earnings released on 7 Aug 2024
EPS came in at $0.33 surpassing the estimated $0.25 by +32.00%, while revenue for the quarter reached $99.01M , beating expectations by +4.00%.
Earnings released on 7 May 2024
EPS came in at $0.06 surpassing the estimated $0.05 by +20.00%, while revenue for the quarter reached $77.36M , beating expectations by +3.27%.
Earnings released on 26 Feb 2024
EPS came in at $0.24 surpassing the estimated $0.19 by +26.32%, while revenue for the quarter reached $76.27M , beating expectations by +0.50%.
Earnings released on 1 Nov 2023
EPS came in at $0.30 surpassing the estimated $0.20 by +50.00%, while revenue for the quarter reached $80.31M , missing expectations by -0.01%.
Earnings released on 2 Aug 2023
EPS came in at $0.40 surpassing the estimated $0.32 by +25.00%, while revenue for the quarter reached $92.31M , missing expectations by -0.22%.
Earnings released on 3 May 2023
EPS came in at $0.18 surpassing the estimated $0.11 by +63.64%, while revenue for the quarter reached $73.53M , beating expectations by +9.81%.
Earnings released on 21 Feb 2023
EPS came in at $0.12 surpassing the estimated $0.05 by +140.00%, while revenue for the quarter reached $64.04M , missing expectations by -0.12%.
Earnings released on 2 Nov 2022
EPS came in at $0.37 surpassing the estimated $0.21 by +76.19%, while revenue for the quarter reached $76.05M , beating expectations by +1.46%.
Earnings released on 10 Aug 2022
EPS came in at $0.42 surpassing the estimated $0.25 by +68.00%, while revenue for the quarter reached $81.10M , beating expectations by +1.23%.
Earnings released on 4 May 2022
EPS came in at $0.29 surpassing the estimated $0.16 by +81.25%, while revenue for the quarter reached $63.20M , beating expectations by +4.41%.
Earnings released on 23 Feb 2022
EPS came in at $0.19 surpassing the estimated $0.16 by +18.75%, while revenue for the quarter reached $59.00M , missing expectations by -0.82%.
Earnings released on 3 Nov 2021
EPS came in at $0.21 surpassing the estimated $0.16 by +31.25%, while revenue for the quarter reached $58.35M , beating expectations by +22.22%.
Earnings released on 4 Aug 2021
EPS came in at $0.27 surpassing the estimated $0.08 by +237.50%, while revenue for the quarter reached $62.37M , beating expectations by +18.73%.
Earnings released on 5 May 2021
EPS came in at $0.20 surpassing the estimated $0.01 by +1.60K%, while revenue for the quarter reached $50.75M , beating expectations by +14.25%.
Earnings released on 24 Feb 2021
EPS came in at $0.14 surpassing the estimated $0.09 by +55.56%, while revenue for the quarter reached $46.00M , beating expectations by +21.21%.
Earnings released on 4 Nov 2020
EPS came in at $0.14 surpassing the estimated $0.09 by +55.56%, while revenue for the quarter reached $47.08M , beating expectations by +100.00%.
STAA Stock Performance
Access detailed STAA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.